Phoenixin

Overview

Phoenixin (PNX) is a neuropeptide identified in 2013 by Yosten and colleagues at Saint Louis University using a bioinformatics approach that screened the human genome for conserved prohormone sequences predicted to produce bioactive peptides. The name was inspired by the phoenix, symbolizing the peptide's emergence from genomic data analysis. Two bioactive forms exist: phoenixin-14 (PNX-14) and phoenixin-20 (PNX-20), derived from the precursor protein SMIM20 (small integral membrane protein 20).

Phoenixin was one of the first neuropeptides discovered primarily through computational genomics rather than traditional biochemical purification, representing a shift in peptide discovery methodology. Its receptor, GPR173 (also known as SREB3, super conserved receptor expressed in brain 3), was subsequently identified through reverse pharmacology approaches, though this receptor assignment has been debated.

Despite being discovered only recently, phoenixin has rapidly accumulated a body of research linking it to anxiety regulation, reproductive endocrinology (particularly GnRH and kisspeptin signaling), pain modulation, inflammation, and feeding behavior. Its wide distribution in the hypothalamus, hippocampus, and spinal cord suggests it participates in fundamental neuroendocrine and behavioral circuits.

Amino Acid Sequences

Both forms are derived from the SMIM20 precursor protein:

PNX-14: DVQPPGLKVWSDPF-NH₂ (14 amino acids) PNX-20: AGALDVQPPGLKVWSDPF-NH₂ (20 amino acids)

• Molecular weight: PNX-14: ~1,570 g/mol; PNX-20: ~2,113 g/mol
• Gene: SMIM20 (chromosome 12q12)
• Receptor: GPR173 (proposed)

Structural features:

• C-terminal amidation — characteristic of bioactive neuropeptides; predicted by the bioinformatics approach that identified phoenixin
• High evolutionary conservation — the PNX-14 sequence is 100% identical across mammals and highly conserved in lower vertebrates, suggesting strong functional selection
• C-terminal WSDPF motif — particularly well conserved; likely critical for receptor binding
• Both PNX-14 and PNX-20 are biologically active, with PNX-20 generally showing higher potency in reproduction-related assays

Mechanism of Action

GPR173 Signaling

GPR173 is an orphan GPCR of the SREB (super conserved receptor expressed in brain) family:

• Proposed as the phoenixin receptor based on cellular binding and functional assays
• Expressed in hypothalamus, hippocampus, pituitary, ovary, and spinal cord
• Signaling: Increases intracellular cAMP and activates CREB (cAMP response element-binding protein) phosphorylation
• The receptor assignment remains somewhat provisional; additional binding partners may exist

Reproductive Regulation

• Phoenixin stimulates GnRH neuron activity in the hypothalamus
• Increases GnRH secretion and subsequent LH release
• Upregulates GnRH receptor expression on pituitary gonadotrophs
• Enhances kisspeptin expression in the hypothalamus, potentially acting upstream of the kisspeptin-GnRH cascade
• PNX-20 is more potent than PNX-14 for reproductive endpoints
• Phoenixin levels fluctuate across the estrous/menstrual cycle, suggesting physiological involvement

Anxiolytic Effects

• Central administration of phoenixin reduces anxiety-like behavior in rodent models (elevated plus maze, open field)
• Mechanism may involve GABA-ergic modulation and interaction with the oxytocinergic system
• Phoenixin expression in the amygdala and hippocampus is consistent with a role in emotional processing
• Some evidence for antidepressant-like properties

Pain Modulation

• Phoenixin is expressed in dorsal root ganglia and spinal cord dorsal horn
• Intrathecal phoenixin produces antinociceptive effects in inflammatory pain models
• May modulate pain through interaction with opioidergic and GABAergic pathways
• Peripheral anti-inflammatory effects reduce pain-associated inflammation

Research Summary

Pharmacokinetics

• Half-life: Not precisely determined in vivo; estimated minutes range based on peptide size and amidation
• Route (research): Intracerebroventricular, intrathecal, intraperitoneal (animal studies)
• Expression: Hypothalamus (particularly median eminence, arcuate nucleus), hippocampus, amygdala, spinal cord, pituitary, heart, GI tract, ovary
• Circulating levels: Detectable in human plasma (~0.5-2 ng/mL); may function as both neuropeptide and circulating hormone
• BBB penetration: Evidence for limited blood-brain barrier crossing; peripheral administration produces some central effects

Common Discussion Topics

1. Genomics-first peptide discovery — Phoenixin exemplifies a modern approach to neuropeptide discovery: bioinformatics screening for conserved prohormone motifs, followed by synthesis and functional characterization. This method has yielded several novel peptides including spexin.

2. Kisspeptin-GnRH axis modulation — Phoenixin's ability to enhance kisspeptin expression and stimulate GnRH release positions it as a potential upstream regulator of the reproductive axis, with implications for fertility research.

3. Receptor controversy — While GPR173 is the leading receptor candidate, some researchers question whether it fully accounts for phoenixin's diverse effects. The possibility of additional receptors or co-receptors remains open.

4. Anxiolytic potential — The anxiolytic effects of phoenixin, combined with its influence on reproduction and pain, suggest it could be relevant to conditions where anxiety, reproductive dysfunction, and chronic pain co-occur.

5. Evolutionary conservation — The remarkable conservation of PNX-14 across species (identical sequence in mammals) indicates strong purifying selection, suggesting essential biological functions that have been maintained for millions of years.

Related Compounds

• Kisspeptin — neuropeptide regulating GnRH neurons; may be modulated by phoenixin
• GnRH — hypothalamic hormone downstream of phoenixin's reproductive effects
• Spexin — another recently discovered metabolic neuropeptide identified by similar bioinformatics approaches
• Galanin — neuropeptide involved in feeding, pain, and mood regulation
• Orexin-A — hypothalamic neuropeptide involved in arousal and feeding